Effect Of Growth Hormone (GH) During Puberty In GH-deficient Children
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation- Clipboard
- My Bibliography
- Collections
- Citation manager
Save citation to file
Format: Summary (text) PubMed PMID Abstract (text) CSV Create file CancelEmail citation
Email address has not been verified. Go to My NCBI account settings to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email CancelAdd to Collections
- Create a new collection
- Add to an existing collection
Add to My Bibliography
- My Bibliography
Your saved search
Name of saved search: Search terms: Test search terms Would you like email updates of new search results? Saved Search Alert Radio Buttons- Yes
- No
Create a file for external citation management software
Create file CancelYour RSS Feed
Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link CopyFull text links
Wiley Full text links Actions
CiteCollectionsAdd to Collections- Create a new collection
- Add to an existing collection
Page navigation
- Title & authors
- Abstract
- Publication types
- MeSH terms
- Substances
- LinkOut - more resources
Abstract
This paper reports results from an ongoing, randomized, multicentre national trial. The aim is to elucidate whether a dose of growth hormone (GH) of 0.2 IU/kg (0.07 mg/kg), given either as once-daily or twice-daily injections during puberty, is more effective than a once-daily dose of 0.1 IU/kg/day (0.03 mg/kg/day) in improving final height in children with GH deficiency (GHD). The twice-daily regimen comes closer to the spontaneous GH secretion pattern in puberty. Ninety-two children with GHD who had been receiving GH therapy for at least 1 year, and with spontaneous puberty or who were prepubertal and due to be started on replacement therapy to induce puberty, were randomly assigned to receive GH as follows: group A, 0.1 IU/kg/day (0.03 mg/kg/day), administered once daily; group B, 0.2 IU/kg/day (0.07 mg/kg/day), administered once daily; and group C, 0.2 IU/kg/day (0.07 mg/kg/day), divided into two equal injections given at 12-hour intervals. Pubertal height gain was 0.7, 0.7 and 1.3 SDS for groups A, B and C, respectively. The gain in height during puberty was thus most marked in group C. Mean final height, when corrected for parental height, was between 0 and 1 SDS in all treatment groups. All but seven children reached a final height within +/- 2 SD of the general population. There was a wide range of final heights in all three treatment groups. This variation in response suggests the need to individualize treatment in order to achieve an appropriate final height for most individuals.
PubMed Disclaimer
Publication types
- Clinical Trial Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Comparative Study Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Multicenter Study Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Randomized Controlled Trial Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Research Support, Non-U.S. Gov't Actions
- Search in PubMed
- Search in MeSH
- Add to Search
MeSH terms
- Adolescent Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Body Height / drug effects* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Child Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Dose-Response Relationship, Drug Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Drug Administration Schedule Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Female Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Follow-Up Studies Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Growth Disorders / drug therapy* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Growth Disorders / etiology Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Human Growth Hormone / administration & dosage* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Human Growth Hormone / deficiency* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Humans Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Male Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Puberty / physiology Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Sweden Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Treatment Outcome Actions
- Search in PubMed
- Search in MeSH
- Add to Search
Substances
- Human Growth Hormone Actions
- Search in PubMed
- Search in MeSH
- Add to Search
LinkOut - more resources
Full Text Sources
- Wiley
Medical
- MedlinePlus Health Information
Wiley [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM Send To - Clipboard
- Save
- My Bibliography
- Collections
- Citation Manager
NCBI Literature Resources
MeSH PMC Bookshelf Disclaimer
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
Từ khóa » Gh Ui Mg
-
Thiếu Hormone Tăng Trưởng ở Trẻ Em - Phiên Bản Dành Cho Chuyên Gia
-
Conversor De Unidades Internacionais V. 3.2.4 - MY PHARMA TOOLS
-
[PDF] 3UI = 1mg 1UI = 0,333mg - Pfizer
-
High-dose Growth Hormone (GH) Treatment In Prepubertal ... - PubMed
-
Growth Hormone - Wikipedia
-
Converting Between IU And Mg/mcg
-
Dosing & Pen Selection | HCP | Humatrope® (somatropin) For Injection
-
3 Công Khai - Trường Đại Học Hải Dương
-
Norditropin NordiFlex 15 Mg/1.5 Ml - Patient Information Leaflet (PIL)
-
Guidelines For Growth Hormone And Insulin-Like Growth Factor-I ...